Advertisement
<< Back To Article
Ocaliva Improves Liver Fibrosis in People With NASH

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

1 Comments

Robert

This way of communicating (in the subtitle) is still limited: you write "about 1/4 of patients taking Ocaliva improve fibrosis". Indeed, but it is not 25%, but 23%, and above all to compare with the 12% of the placebo ... However, what many will remember is a fibrotic efficacy on 25% of the treated population while 'we are far from it ... we are closer to half of this figure, with in addition a significant non-resolution of NASH and an addition of statins in many cases which can also have a role

January 5, 2020

Advertisement

Hot topics


Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.